Also trades as: 3613.HK (HKSE) · $vol 1M
BJTRF OTC
Beijing Tong Ren Tang Chinese Medicine Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.1%
5Y: -46.0%
$0.65
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$194M
-87.9% ▼
5Y CAGR: +2.8%
Gross Profit
$119M
-88.8% ▼
5Y CAGR: -0.4%
Operating Income
$61M
-89.5% ▼
5Y CAGR: -6.8%
Net Income
$51M
-20.7% ▼
5Y CAGR: -6.1%
EPS (Diluted)
$0.06
-89.8% ▼
5Y CAGR: -6.1%
EBITDA
$73M
-21.0% ▼
5Y CAGR: -5.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $200M | $222M | $195M | $1.6B | $194M |
| YoY Growth | +17.6% | +11.1% | -11.9% | +725.2% | -87.9% |
| Cost of Revenue | $57M | $83M | $61M | $546M | $76M |
| Gross Profit | $143M | $139M | $134M | $1.1B | $119M |
| Gross Margin | 71.4% | 62.7% | 68.7% | 66.1% | 61.2% |
| R&D Expenses | $1M | $986K | $2M | $1M | $1M |
| SG&A Expenses | $342M | $342M | $410M | $53M | $57M |
| Operating Expenses | $44M | $36M | $54M | $54M | $58M |
| Operating Income | $99M | $104M | $80M | $577M | $61M |
| Operating Margin | 49.5% | 46.9% | 40.9% | 35.8% | 31.3% |
| Interest Expense | $604K | $597K | $6M | $834K | $727K |
| Income Before Tax | $100M | $106M | $88M | $81M | $65M |
| Tax Expense | $16M | $17M | $12M | $13M | $11M |
| Net Income | $78M | $83M | $540M | $64M | $51M |
| Net Margin | 39.1% | 37.3% | 276.7% | 4.0% | 26.2% |
| EPS (Diluted) | $0.09 | $0.10 | $0.08 | $0.60 | $0.06 |
| EBITDA | $101M | $105M | $82M | $93M | $73M |
| Shares Outstanding | 837M | 837M | 837M | 837M | 837M |